Roivant Sciences (ROIV) Assets Average (2021 - 2026)
Roivant Sciences (ROIV) reported Assets Average of $5.5 billion for Q1 2026, down 2.63% on a YoY basis from $5.6 billion in Q1 2025, and up 6.28% quarter-over-quarter from $5.1 billion in Q4 2025.
Roivant Sciences (ROIV) Assets Average (2021 - 2026) Analysis & Trends
Roivant Sciences has reported Assets Average for 6 years, with the latest figure at $5.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 2.63% year-over-year to $5.5 billion; the trailing twelve-month figure through Mar 2026 stood at $5.5 billion (down 2.63% YoY), and the FY2026 full-year result was $5.5 billion, down 2.63% from the prior year.
- Assets Average for Q1 2026 stood at $5.5 billion, up from $5.1 billion in the prior quarter.
- The five-year high for Assets Average was $7.3 billion in Q1 2024, with the low at $2.1 billion in Q3 2023.
- Historically, Assets Average has averaged $4.4 billion across 5 years, with a median of $5.0 billion in 2025.
- Annual changes were most pronounced in 2022 — Assets Average dropped 25.14% — and 2024, when it soared 216.49%.
- Roivant Sciences' Assets Average stood at $2.2 billion in 2022, then surged by 112.25% to $4.7 billion in 2023, then gained by 27.94% to $6.0 billion in 2024, then fell by 14.26% to $5.1 billion in 2025, then grew by 6.28% to $5.5 billion in 2026.
- The last three Assets Average figures came in at $5.5 billion (Q1 2026), $5.1 billion (Q4 2025), and $5.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | 5.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Bn |
| Dec 31, 2025 | 5.14 Bn |
| Sep 30, 2025 | 5.05 Bn |
| Jun 30, 2025 | 5.23 Bn |
| Mar 31, 2025 | 5.61 Bn |
| Dec 31, 2024 | 6.00 Bn |
| Sep 30, 2024 | 6.35 Bn |
| Jun 30, 2024 | 6.86 Bn |
| Mar 31, 2024 | 7.27 Bn |
| Dec 31, 2023 | 4.69 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 2.26 Bn |
| Mar 31, 2023 | 2.30 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 2.69 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 2.78 Bn |
| Jun 30, 2021 | 2.52 Bn |